Ep 49: Melanoma Patient Network Europe with Bettina Ryll
Melanoma Matters14 Okt 2024

Ep 49: Melanoma Patient Network Europe with Bettina Ryll

Summary

In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Bettina Ryll, founder of the Melanoma Patient Network Europe (MPNE). Bettina shares her personal journey from being a physician to becoming a patient advocate after her husband's battle with metastatic melanoma. The conversation explores the evolution of patient support networks, the challenges faced in healthcare systems, and complex adaptive systems. Bettina emphasizes the need for systemic change to improve patient access to treatments and highlights the importance of understanding the interconnectedness of healthcare, economics, and patient outcomes.


Keywords

melanoma, patient advocacy, healthcare systems, immunotherapy, patient networks, Bettina Ryll, MPNE, clinical trials, healthcare access, systemic change


Takeaways

Bettina Ryll founded MPNE after her husband's battle with melanoma.

Patient networks are crucial for sharing knowledge and support.

Understanding the healthcare system is key to advocating for patients.

Immunotherapy presents complex challenges that need addressing.

Systemic change is necessary for improving patient access to treatments.

The pharmaceutical landscape is influenced by economic factors.

Patients should not be treated as victims of their circumstances.

Action is often more effective than extensive planning.

Collaboration and community (and ferocious energy) are essential for driving change.


Sound Bites

"I just started explaining science."

"We are sentinels for issues."

"We must be standing for something."


Chapters

00:00 Introduction to Bettina Ryll

06:19 The Formation of Melanoma Patient Network Europe

11:51 Understanding Patient Needs and Systemic Issues

17:54 Challenges in Immunotherapy and Clinical Trials

23:47 Healthcare and Patient Access as Complex Adaptive Systems

29:25 The Role of Community and Collaboration in Change

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(87)

Ep 83: Guest Megan Othus and Time of Day Administration

Ep 83: Guest Megan Othus and Time of Day Administration

James and Sapna welcome Megan Othus, Professor of Biostatistics at the Fred Hutch Cancer Center and one of the key statisticians at SWOG.Megan talks about growing up in the PNW and going East to get b...

24 Jun 40min

Ep 82: Best of ASCO: 2026

Ep 82: Best of ASCO: 2026

In this episode, James & Sapna tease the size of ASCO and ESMO and number of simultaneous publications.They review the most impactful melanoma and Merkel cell carcinoma presentations from ASCO 2026, f...

13 Jun 1h 4min

Live from ASCO 2026: a preview

Live from ASCO 2026: a preview

James & Sapna sent a brief message from ASCO 2026 about what they are looking forward to hearing at the meeting.OptimUM-02ADAMKN-942Neoadjuvant pilot studies... and more

1 Jun 6min

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Feb 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Des 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Des 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Des 20251min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...

29 Des 202537min

Populært innen Helse

fastlegen
hvordan-har-du-det-mann
rss-gukild-johaug
psykodrama
leger-om-livet
lydartikler-fra-aftenposten
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
rss-garne-damer
g-punktet
rss-kunsten-a-leve
klimaks
treningsprat
rss-skravla-gar
helsetipspodden
kjed-deg-i-sovn-verdens-kjedeligste-podcast
sinnsyn